Posted on September 22, 2008 by crimsoncanary
ImClone Systems have announced that erbitux (cetuximab) has been commercially launched in Japan for use in treating patients with advanced or metastatic colorectal cancer.
Filed under: Uncategorized | Tagged: BMS, cetuximab, erbitux, HER1, ImClone, Merck KGaA, Merck-Serono | Comments Off
Posted on September 22, 2008 by crimsoncanary
Researchers from Sejong University and the Korea Research Institute of Bioscience and Biotechnology have published a series of ERK2 inhibitors
Filed under: kinase | Tagged: erk2, kinase, MAPK1, preclinica, Research | Comments Off
